Innovative Cardiovascular Medicine (National Cerebral and Cardiovascular Center)
To Promote Basic, Clinical and Translational Research in National Cerebral and Cardiovascular Center Which Possesses Abundant Patients and Research Institute.
Medical Sciences Course
- Master / Doctoral Degree
- YASUDA, Satoshi
yasuda.satoshi.hp*mail.ncvc.go.jp (Please convert "*" into "@".)
- Imaging and biomarker technology of high-risk plaque for acute coronary syndrome
- Cardiovascular protection in heart diseases
- The pathological role of inflammation in the process of left ventricular remodeling
ischemic heart diseases, atherosclerosis, heart failure
biomarker, imaging, preemptive medicine
National Cerebral and Cardiovascular Center is characterized as 1) abundant patients, 2) highly specialized physician, 3) modern medical equipment, 4) close collaboration among hospital, research institute and research and development initiative center and 5) facilitating biobank. In particular, our laboratory focuses on a biomarker study to identify high-risk patients susceptible to future coronary events and advances preemptive medicine for early intervention.
Figure 1. Preemptive Medicine Targeting Biomarker
Figure 2. Translational Research: Bioactive Peptide as a Therapeutic Target
- Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T, Nagai T, NakaoK, Fujino M, Nagatsuka K, Ishibashi-Ueda H, Nishimura K, Miyamoto Y, Kusano K,Anzai T, Goto Y, Ogawa H, Yasuda S. Prevalence, Clinical Features, and Prognosis of Ac